Parliamentary Search

Statutory instrument laid in the House of Commons and House of Lords, on Monday, 7 April 2008 on behalf of the Department of Health. It was made on Monday, 31 March 2008.

Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 2008

SI 2008/941. (Negative instrument). Together with an explanatory memorandum and impact assessment from the Department of Health. Coming into force 1 May 2008. Amends SI 2004/1031 and SI 2005/50.

Secondary information

Type
Statutory instrument
Reference
SI 2008/941 
Session
2007-08
Coming into force
Thursday, 1 May 2008
Procedure
Negative
Related items
Medicines for Human Use (Clinical Trials) Regulations 2004
Thursday, 1 April 2004
Statutory instruments
House of Commons
House of Lords
Blood Safety and Quality Regulations 2005
Tuesday, 18 January 2005
Statutory instruments
House of Commons
House of Lords
EC documents
DIR2001/20/EC; DIR2001/83/EC
Contains impact assessment
Yes
Subjects
Children Blood Genetics EU law Drugs Ethics Standards Regulation Safety United Kingdom Ethics Committees Authority Clinical trials Gene Therapy Advisory Committee
Legislation
European Communities Act 1972
Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 2008
Library location
Commons Library: UP 687 2007-08
Link
View this Statutory instrument on www.legislation.gov.uk